Injectable GLP-1 medications are peptide-based drugs administered via subcutaneous injection, bypassing the gastrointestinal tract for absorption
The peptide amplifies what youre already doing
Result Genetically proxied GLP-1RA exposure was associated with a lower risk of schizophrenia (OR = 0.72, 95% CI [0.610.86]), bipolar disorder (OR = 0.91, 95% CI [0.880.94]), bulimia nervosa (OR = 0.34, 95% CI [0.230.52]), post-traumatic stress disorder (PTSD) (OR = 0.45, 95% CI [0.310.67]), and autism (OR = 0.55, 95% CI [0.320.93]), all P 1%) significantly ( p 0.001
1AG), denoted only by a moderate reduction in HOMA-IR (Fig
Limit of one (1) Discount per customer/transaction
Treatment logistics are simple: an intramuscular injection into the upper arm or glute, typically weekly, from a licensed provider, with mild possible injection-site effects and ongoing clinical oversight